Global Natural Food Colorants Market Size To Worth USD 4.55 Billion By 2033 | CAGR of 8.79%
September 06, 2024 20:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Sept. 06, 2024 (GLOBE NEWSWIRE) -- The Global Natural Food Colorants Market Size is to Grow from USD 1.96 Billion in 2023 to USD 4.55 Billion by 2033, at a Compound Annual...
Global Electric Hair Clipper and Trimmer Market Size To Worth USD 8.4 Billion By 2033 | CAGR Of 3.42%
September 06, 2024 03:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Sept. 06, 2024 (GLOBE NEWSWIRE) -- The Global Electric Hair Clipper and Trimmer Market Size is Expected to Grow from USD 6.0 Billion in 2023 to USD 8.4 Billion by 2033, at...
UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
September 05, 2024 20:43 ET
|
Ocuphire Pharma
Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025 Top-line data from LYNX-2 Phase 3 trial in patients with decreased visual acuity under low light conditions following...
Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
September 05, 2024 08:00 ET
|
Ocuphire Pharma
Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025 Top-line data from LYNX-2 Phase 3 trial in patients with decreased visual acuity under low light conditions following...
PlantX Announces Filing of Interim Financial Statements for the Three Months Ended June 30, 2024
August 29, 2024 23:14 ET
|
PlantX Life Inc.
VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company”), the digital face of the plant-based...
Reducing Handoff Communication Failures and Inequities in Healthcare
August 22, 2024 12:25 ET
|
The Joint Commission
OAKBROOK TERRACE, Illinois, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inspiring studies related to two common sources of adverse events in healthcare – handoff communication failures, and bias and...
Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024
August 20, 2024 07:29 ET
|
Navios Maritime Partners L.P.
Revenue: $342.2 million for Q2 2024$660.7 million for H1 2024 Net Income: $101.5 million for Q2 2024$174.8 million for H1 2024 Earnings per common unit: $3.30 for Q2 2024$5.68 for H1 2024 Net cash...
Navigator Gas Reports Second Quarter 2024 Results
August 14, 2024 16:15 ET
|
Navigator Holdings Ltd.
LONDON, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Financial Highlights On August 14, 2024, the Board of Navigator Holdings Ltd. (NYSE: NVGS) declared a cash dividend of $0.05 per share for the...
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
August 13, 2024 08:00 ET
|
Ocuphire Pharma
VEGA-3 Phase 3 Study of Phentolamine Ophthalmic Solution in Presbyopia is Recruiting Patients with Top-Line Data Expected in 2025 LYNX-2 Phase 3 Study of Phentolamine Ophthalmic Solution...
The independent committee of the Board of Directors of Millicom (Tigo) continues to believe the public cash offers made by Atlas Luxco S.à r.l. significantly undervalue Millicom’s shares and SDRs and reiterates recommendation not to tender
August 09, 2024 08:10 ET
|
Millicom International Cellular S.A.
The independent committee of the Board of Directors of Millicom (Tigo) continues to believe the public cash offers made by Atlas Luxco S.à r.l. significantly undervalue Millicom’s shares and SDRs and...